DrFirst vs AbbVie
Side-by-side comparison of AI visibility scores, market position, and capabilities
E-prescribing, medication history, and patient safety platform processing hundreds of millions of Rx transactions annually. Rockville MD; founded 2000; embedded in hundreds of EHR and clinical workflow platforms;
About
DrFirst is a health IT company that has been at the forefront of e-prescribing and medication management since its founding in 2000. Headquartered in Rockville, Maryland, DrFirst provides e-prescribing for controlled substances (EPCS), medication history retrieval, clinical decision support, and patient medication adherence tools to hospitals, physician practices, long-term care facilities, and health IT vendors. The company processes hundreds of millions of prescription transactions annually and is embedded in a wide range of EHR and clinical workflow platforms through its APIs and SDK integrations.\n\nDrFirst's flagship EPCS solution was among the earliest to achieve DEA compliance for electronic prescribing of controlled substances, a capability that has become essential as regulatory requirements and clinical adoption have expanded across all states. The company's medication history service aggregates pharmacy and payer claims data to give providers a more complete view of a patient's actual medication use, supporting medication reconciliation at transitions of care and reducing adverse drug events. DrFirst also offers Backline, a secure clinical communication platform for care team messaging.\n\nDrFirst occupies a specialized but critical position in the health IT ecosystem, providing medication-related infrastructure that EHR vendors embed in their platforms rather than build independently. This embedded model gives DrFirst broad distribution across the provider market and creates sticky, long-term customer relationships. The company has invested in expanding its clinical intelligence capabilities, including AI-driven prior authorization for specialty medications and smart alerts that surface relevant clinical guidance at the point of prescribing.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
About
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.